These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 12501877)

  • 1. The effect of zanamivir treatment on influenza complications: a retrospective cohort study.
    Cole JA; Loughlin JE; Ajene AN; Rosenberg DM; Cook SE; Walker AM
    Clin Ther; 2002 Nov; 24(11):1824-39. PubMed ID: 12501877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk for respiratory events in a cohort of patients receiving inhaled zanamivir: a retrospective study.
    Loughlin JE; Alfredson TD; Ajene AN; Cole JA; Cook SE; Rosenberg DM; Walker AM
    Clin Ther; 2002 Nov; 24(11):1786-99. PubMed ID: 12501874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of zanamivir on antibiotic use for respiratory events following acute influenza in adolescents and adults.
    Kaiser L; Keene ON; Hammond JM; Elliott M; Hayden FG
    Arch Intern Med; 2000 Nov; 160(21):3234-40. PubMed ID: 11088083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oseltamivir and the risk of influenza-related complications and hospitalizations in patients with diabetes.
    Orzeck EA; Shi N; Blumentals WA
    Clin Ther; 2007 Oct; 29(10):2246-55. PubMed ID: 18042482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zanamivir for the treatment of influenza A and B infection in high-risk patients: a pooled analysis of randomized controlled trials.
    Lalezari J; Campion K; Keene O; Silagy C
    Arch Intern Med; 2001 Jan; 161(2):212-7. PubMed ID: 11176734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zanamivir: a review of clinical safety in individuals at high risk of developing influenza-related complications.
    Gravenstein S; Johnston SL; Loeschel E; Webster A
    Drug Saf; 2001; 24(15):1113-25. PubMed ID: 11772145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuraminidase inhibitors for preventing and treating influenza in children.
    Matheson NJ; Symmonds-Abrahams M; Sheikh A; Shepperd S; Harnden A
    Cochrane Database Syst Rev; 2003; (3):CD002744. PubMed ID: 12917931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Patient assessment for zanamivir therapy (second report) -- a survey of patients with influenza who were prescribed zanamivir during the 2001/2002 season in Japan].
    Matsumoto K; Kudoh S; Sugaya N; Suzuki H
    Kansenshogaku Zasshi; 2002 Dec; 76(12):1016-24. PubMed ID: 12607348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zanamivir is an effective treatment for influenza in children undergoing therapy for acute lymphoblastic leukemia.
    Maeda M; Fukunaga Y; Asano T; Migita M; Ueda T; Hayakawa J
    Scand J Infect Dis; 2002; 34(8):632-3. PubMed ID: 12238587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influenza virus and rhinovirus-related otitis media: potential for antiviral intervention.
    Hayden FG
    Vaccine; 2000 Dec; 19 Suppl 1():S66-70. PubMed ID: 11163466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of zanamivir on duration and resolution of influenza symptoms.
    Monto AS; Moult AB; Sharp SJ
    Clin Ther; 2000 Nov; 22(11):1294-305. PubMed ID: 11117654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiviral drugs in influenza: an adjunct to vaccination in some situations.
    Prescrire Int; 2006 Feb; 15(81):21-30. PubMed ID: 16548114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug under test: influenza--Relenza in daily practice. Experience during the influenza season 1999/2000.
    Schmidt RE
    Med Microbiol Immunol; 2002 Dec; 191(3-4):175-9. PubMed ID: 12458355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical efficacy and safety of the orally inhaled neuraminidase inhibitor zanamivir in the treatment of influenza: a randomized, double-blind, placebo-controlled European study.
    Mäkelä MJ; Pauksens K; Rostila T; Fleming DM; Man CY; Keene ON; Webster A
    J Infect; 2000 Jan; 40(1):42-8. PubMed ID: 10762110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhaled zanamivir for the prevention of influenza in families. Zanamivir Family Study Group.
    Hayden FG; Gubareva LV; Monto AS; Klein TC; Elliot MJ; Hammond JM; Sharp SJ; Ossi MJ;
    N Engl J Med; 2000 Nov; 343(18):1282-9. PubMed ID: 11058672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [symbol: see text] Zanamivir for influenza.
    Drug Ther Bull; 1999 Nov; 37(11):81-4. PubMed ID: 10696691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of zanamivir in patients with influenza--impact of age, severity of infections and specific risk factors.
    Höffken G; Gillissen A
    Med Microbiol Immunol; 2002 Dec; 191(3-4):169-73. PubMed ID: 12458354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of oseltamivir on the incidence of secondary complications of influenza in adolescent and adult patients: results from a retrospective population-based study.
    Blumentals WA; Schulman KL
    Curr Med Res Opin; 2007 Dec; 23(12):2961-70. PubMed ID: 17939881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuraminidase inhibitors in pediatric patients: potential place in influenza therapy.
    Noyola DE
    Paediatr Drugs; 2003; 5(2):125-31. PubMed ID: 12529164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness analysis of inhaled zanamivir in the treatment of influenza A and B in high-risk patients.
    Griffin AD; Perry AS; Fleming DM
    Pharmacoeconomics; 2001; 19(3):293-301. PubMed ID: 11303417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.